FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996735764> ?p ?o ?g. }

• W1996735764 endingPage "1077" @default.
• W1996735764 startingPage "1073" @default.
• W1996735764 abstract "Radioactive iodine ((131)I) has become the most widely used therapy for patients with hyperthyroidism caused by Graves' disease in the United States. There remains, however, significant variability among (131)I dosing regimens, and it is clear that most patients ultimately develop hypothyroidism after therapy. To avoid persistent hyperthyroidism, we adopted a high dose (131)I therapy protocol based on measurement of 24-h thyroid (123)I uptake designed to deliver 8 mCi (296 MBq) to the thyroid gland 24 h after (131)I administration. To evaluate the efficacy of this protocol, we reviewed our clinical experience over a 7-yr period. We treated 261 patients (219 women and 42 men) with hyperthyroidism caused by Graves' disease with (131)I [mean dose, 14.6 mCi (540 MBq)] between 1993 and 1999. Before treatment, 207 (79%) had received an antithyroid drug (109 propylthiouracil and 98 methimazole). We determined their thyroid status 1 yr after treatment in relation to age, pretreatment with an antithyroid drug, pretreatment thyroid size, and dose of (131)I retained in the thyroid 24 h after treatment. Among the 261 patients, 225 (86%) were euthyroid or hypothyroid 1 yr after treatment, and 36 patients (14%) had persistent hyperthyroidism and required a second treatment. The patients who had persistent hyperthyroidism were younger (P < 0.01), had larger thyroid glands (P < 0.01), higher pretreatment thyroid (123)I uptake values (P < 0.01), and higher serum T(4) concentrations (P < 0.01) and were more likely to have taken antithyroid medication before administration of (131)I (P = 0.01). Five of these patients developed transient hypothyroidism, followed by thyrotoxicosis. There was an asymptotic, inverse relationship between the retained dose of (131)I at 24 h and persistent hyperthyroidism, revealing a 5-10% failure rate despite delivery of up to 400 microCi (14.8 MBq)/g. A dose of (131)I that results in accumulation of 8 mCi (296 MBq) in the thyroid gland 24 h after administration is an effective treatment for the majority of patients with Graves' hyperthyroidism. Young patients with larger thyroid glands, higher serum T(4) concentrations, and higher 24-h thyroid (123)I uptake values, and those pretreated with antithyroid medication for greater than 4 months are at higher risk for treatment failure. A higher dose of (131)I may be advisable in such patients." @default.
• W1996735764 created "2016-06-24" @default.
• W1996735764 creator A5045758821 @default.
• W1996735764 creator A5089114785 @default.
• W1996735764 date "2002-03-01" @default.
• W1996735764 modified "2023-09-27" @default.
• W1996735764 title "High Dose¹³¹I Therapy for the Treatment of Hyperthyroidism Caused by Graves’ Disease" @default.
• W1996735764 cites W1530387160 @default.
• W1996735764 cites W1891948454 @default.
• W1996735764 cites W1893911450 @default.
• W1996735764 cites W1964426807 @default.
• W1996735764 cites W1965139996 @default.
• W1996735764 cites W1968489171 @default.
• W1996735764 cites W1982607912 @default.
• W1996735764 cites W1997539630 @default.
• W1996735764 cites W2007529288 @default.
• W1996735764 cites W2008453353 @default.
• W1996735764 cites W2008704094 @default.
• W1996735764 cites W2028309686 @default.
• W1996735764 cites W2028456751 @default.
• W1996735764 cites W2029671093 @default.
• W1996735764 cites W2038217607 @default.
• W1996735764 cites W2051202188 @default.
• W1996735764 cites W2062980914 @default.
• W1996735764 cites W2064969958 @default.
• W1996735764 cites W2071254731 @default.
• W1996735764 cites W2086890388 @default.
• W1996735764 cites W2092026686 @default.
• W1996735764 cites W2096335627 @default.
• W1996735764 cites W2110980064 @default.
• W1996735764 cites W2162111182 @default.
• W1996735764 cites W2170312712 @default.
• W1996735764 cites W321784 @default.
• W1996735764 doi "https://doi.org/10.1210/jcem.87.3.8333" @default.
• W1996735764 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11889166" @default.
• W1996735764 hasPublicationYear "2002" @default.
• W1996735764 type Work @default.
• W1996735764 sameAs 1996735764 @default.
• W1996735764 citedByCount "89" @default.
• W1996735764 countsByYear W19967357642012 @default.
• W1996735764 countsByYear W19967357642013 @default.
• W1996735764 countsByYear W19967357642014 @default.
• W1996735764 countsByYear W19967357642015 @default.
• W1996735764 countsByYear W19967357642016 @default.
• W1996735764 countsByYear W19967357642017 @default.
• W1996735764 countsByYear W19967357642018 @default.
• W1996735764 countsByYear W19967357642019 @default.
• W1996735764 countsByYear W19967357642020 @default.
• W1996735764 countsByYear W19967357642021 @default.
• W1996735764 countsByYear W19967357642022 @default.
• W1996735764 countsByYear W19967357642023 @default.
• W1996735764 crossrefType "journal-article" @default.
• W1996735764 hasAuthorship W1996735764A5045758821 @default.
• W1996735764 hasAuthorship W1996735764A5089114785 @default.
• W1996735764 hasBestOaLocation W19967357641 @default.
• W1996735764 hasConcept C126322002 @default.
• W1996735764 hasConcept C134018914 @default.
• W1996735764 hasConcept C158479217 @default.
• W1996735764 hasConcept C2775960720 @default.
• W1996735764 hasConcept C2776606491 @default.
• W1996735764 hasConcept C2776652619 @default.
• W1996735764 hasConcept C2777195454 @default.
• W1996735764 hasConcept C2777288759 @default.
• W1996735764 hasConcept C2909564963 @default.
• W1996735764 hasConcept C526584372 @default.
• W1996735764 hasConcept C71924100 @default.
• W1996735764 hasConcept C90924648 @default.
• W1996735764 hasConceptScore W1996735764C126322002 @default.
• W1996735764 hasConceptScore W1996735764C134018914 @default.
• W1996735764 hasConceptScore W1996735764C158479217 @default.
• W1996735764 hasConceptScore W1996735764C2775960720 @default.
• W1996735764 hasConceptScore W1996735764C2776606491 @default.
• W1996735764 hasConceptScore W1996735764C2776652619 @default.
• W1996735764 hasConceptScore W1996735764C2777195454 @default.
• W1996735764 hasConceptScore W1996735764C2777288759 @default.
• W1996735764 hasConceptScore W1996735764C2909564963 @default.
• W1996735764 hasConceptScore W1996735764C526584372 @default.
• W1996735764 hasConceptScore W1996735764C71924100 @default.
• W1996735764 hasConceptScore W1996735764C90924648 @default.
• W1996735764 hasIssue "3" @default.
• W1996735764 hasLocation W19967357641 @default.
• W1996735764 hasLocation W19967357642 @default.
• W1996735764 hasOpenAccess W1996735764 @default.
• W1996735764 hasPrimaryLocation W19967357641 @default.
• W1996735764 hasRelatedWork W1993024984 @default.
• W1996735764 hasRelatedWork W1996735764 @default.
• W1996735764 hasRelatedWork W2011960454 @default.
• W1996735764 hasRelatedWork W2029175984 @default.
• W1996735764 hasRelatedWork W2114822795 @default.
• W1996735764 hasRelatedWork W2334892312 @default.
• W1996735764 hasRelatedWork W2482385451 @default.
• W1996735764 hasRelatedWork W2784812294 @default.
• W1996735764 hasRelatedWork W3205979 @default.
• W1996735764 hasRelatedWork W4312237781 @default.
• W1996735764 hasVolume "87" @default.
• W1996735764 isParatext "false" @default.
• W1996735764 isRetracted "false" @default.
• W1996735764 magId "1996735764" @default.

• next